{
    "organizations": [],
    "uuid": "1cc0cdad4bd9de958d75cf6d3037e2f652a9945f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-biofrontera-european-commission-ap/brief-biofrontera-european-commission-approves-use-of-ameluz-in-combination-with-daylight-photodynamic-therapy-idUSFWN1QN0I4",
    "ord_in_thread": 0,
    "title": "BRIEF-Biofrontera: European Commission Approves Use Of Ameluz In Combination With Daylight Photodynamic Therapy",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 5 (Reuters) - Biofrontera AG:\n* PTA-ADHOC: BIOFRONTERA AG: EUROPEAN COMMISSION APPROVES USE OF AMELUZ IN COMBINATION WITH DAYLIGHT PHOTODYNAMIC THERAPY Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-03-05T22:06:00.000+02:00",
    "crawled": "2018-03-06T22:17:32.007+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "biofrontera",
        "ag",
        "biofrontera",
        "ag",
        "european",
        "commission",
        "approves",
        "use",
        "ameluz",
        "combination",
        "daylight",
        "photodynamic",
        "therapy",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}